Abstract
One of the major successes of nuclear medicine in recent years has been the clinical utility of the 99mTc-labeled bone-imaging agents. This article is concerned with the evidence available for the mechanisms by which these and other such radiopharmaceuticals localize at sites in the skeleton.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Animals
-
Bone and Bones / metabolism*
-
Collagen / metabolism
-
Diphosphates / metabolism
-
Fluorine / metabolism
-
Gallium / metabolism
-
Hydroxyapatites / metabolism
-
Iron / metabolism
-
Metals, Alkaline Earth / metabolism
-
Metals, Rare Earth / metabolism
-
Organophosphorus Compounds / metabolism
-
Phosphates / metabolism
-
Phosphoric Monoester Hydrolases / metabolism
-
Rabbits
-
Radionuclide Imaging*
-
Rats
-
Technetium / metabolism
Substances
-
Diphosphates
-
Hydroxyapatites
-
Metals, Alkaline Earth
-
Metals, Rare Earth
-
Organophosphorus Compounds
-
Phosphates
-
Fluorine
-
Technetium
-
Collagen
-
Gallium
-
Iron
-
Phosphoric Monoester Hydrolases